Edwards Lifesciences (EW) Depreciation & Amortization (CF) (2009 - 2026)
Edwards Lifesciences (EW) posted quarterly Depreciation & Amortization (CF) of $40.9 million for Q1 2026, up 11.75% year-over-year from $36.6 million in Q1 2025, and down 4.22% quarter-over-quarter from $42.7 million in Q4 2025.
Edwards Lifesciences (EW) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
Edwards Lifesciences' Depreciation & Amortization (CF) history runs 18 years deep, the most recent figure standing at $40.9 million for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 11.75% year-over-year to $40.9 million; the TTM figure through Mar 2026 stood at $160.9 million (up 4.96% YoY), while the FY2025 annual figure was $156.6 million, up 0.9% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $40.9 million, down from $42.7 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $42.7 million in Q4 2025, with the low at $34.1 million in Q2 2022.
- The 5-year median for Depreciation & Amortization (CF) is $36.7 million (2023), against an average of $37.5 million.
- Peak annual rise in Depreciation & Amortization (CF) reached 16.08% in 2024, while the deepest fall reached 6.5% in 2024.
- Edwards Lifesciences' Depreciation & Amortization (CF) stood at $35.4 million in 2022, then increased by 3.67% to $36.7 million in 2023, then advanced by 16.08% to $42.6 million in 2024, then climbed by 0.23% to $42.7 million in 2025, then retreated by 4.22% to $40.9 million in 2026.
- Business Quant data shows EW's Depreciation & Amortization (CF) at $40.9 million in Q1 2026, $42.7 million in Q4 2025, and $39.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.62 Bn | 126.15 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.89 Bn | 110.67 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 74.01 Bn | 73.47 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 52.48 Bn | 48.23 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.64 Bn | 32.69 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.90 Bn | 31.79 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.41 Bn | 23.09 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.16 Bn | 22.68 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Zimmer Biomet Holdings | 19.35 Bn | 18.94 Bn | 1.54 Bn | 270.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.70 Mn |
| Jun 30, 2026 | 42.70 Mn |
| Mar 31, 2026 | 40.90 Mn |
| Mar 31, 2026 | 40.90 Mn |
| Dec 31, 2025 | 42.70 Mn |
| Dec 31, 2025 | 42.70 Mn |
| Sep 30, 2025 | 39.20 Mn |
| Sep 30, 2025 | 39.20 Mn |
| Jun 30, 2025 | 38.10 Mn |
| Jun 30, 2025 | 38.10 Mn |
| Mar 31, 2025 | 36.60 Mn |
| Mar 31, 2025 | 36.60 Mn |
| Dec 31, 2024 | 42.60 Mn |
| Dec 31, 2024 | 42.60 Mn |
| Sep 30, 2024 | 34.50 Mn |
| Sep 30, 2024 | 34.50 Mn |
| Jun 30, 2024 | 39.60 Mn |
| Jun 30, 2024 | 39.60 Mn |
| Mar 31, 2024 | 38.50 Mn |
| Mar 31, 2024 | 38.50 Mn |